Dec 13, 2025 • MarketBeat
BULLISH
BI Asset Management Fondsmaeglerselskab A S Acquires 30,277 Shares of HCA Healthcare, Inc. $HCA
BI Asset Management Fondsmaeglerselskab A S has increased its stake in HCA Healthcare, Inc. by 25.7% in the second quarter, now owning 147,954 shares valued at $56.68 million. This move is part of broader institutional investment activity, with several other firms also adjusting their positions in HCA Healthcare. The article also provides recent analyst ratings, insider trading information, and detailed stock performance metrics for HCA Healthcare.
Dec 12, 2025 • Finviz
NEUTRAL
L1 Capital International Trimmed HCA Healthcare (HCA) Following Share Price Appreciation
L1 Capital International trimmed its investment in HCA Healthcare (NYSE: HCA) after the stock experienced strong share price appreciation. Although HCA remains an investment for the firm, it is no longer a top 10 holding due to a less favorable risk-adjusted return potential at current price levels. The firm noted that the market's view of HCA has become more balanced, diverging from past opportunities when pessimistic views led to attractive entry points.
Dec 12, 2025 • MarketBeat
NEUTRAL
Ilex Capital Partners UK LLP Sells 4,258 Shares of HCA Healthcare, Inc. $HCA
Ilex Capital Partners UK LLP significantly reduced its stake in HCA Healthcare by 52.7%, selling 4,258 shares and retaining 3,822 shares valued at approximately $1.46 million. This follows other institutional investor activities and an insider sale by EVP Michael R. McAlevey, who sold 3,892 shares worth about $1.84 million, cutting his ownership by 52.74%. Despite these sales, HCA Healthcare reported strong quarterly earnings and issued optimistic FY2025 guidance, with analysts maintaining a "Moderate Buy" rating.
Dec 12, 2025 • Insider Monkey
NEUTRAL
L1 Capital International Trimmed HCA Healthcare (HCA) Following Share Price Appreciation
L1 Capital International has reduced its investment in HCA Healthcare, Inc. (NYSE:HCA) after significant appreciation in the stock's share price. While the healthcare provider remains part of the fund's holdings, it is no longer a top 10 position. The firm noted that HCA's current share price reflects more balanced operating expectations, leading to a less favorable risk-adjusted return potential compared to past opportunities when the market was overly pessimistic.
Dec 11, 2025 • HCA Healthcare Today
BULLISH
Meet the Innovators: Nurse executive explores the art of possibility, optimizing care for colleagues and patients
Erica Rossitto, Senior Vice President and Assistant Chief Nurse Executive for HCA Healthcare, leverages her passion for patient care and system organization to drive innovation. She leads the Care Team Optimization (CTO) domain within HCA Healthcare's Digital Transformation and Innovation department, developing technology like the AI-powered Nurse Handoff tool to streamline operations and reduce administrative burdens for clinicians. Her work focuses on enhancing patient care and supporting nurses, ultimately keeping them at the bedside.
Dec 11, 2025 • Nasdaq
SOMEWHAT-BULLISH
Ex-Dividend Reminder: DT Midstream, HCA Healthcare and Thermo Fisher Scientific
This article serves as an ex-dividend reminder for shareholders of DT Midstream (DTM), HCA Healthcare (HCA), and Thermo Fisher Scientific (TMO), as their respective ex-dividend dates are approaching on December 15, 2025. Investors are informed about the upcoming quarterly dividend payments and the expected percentage drop in stock prices when they trade ex-dividend. Dividend history charts and estimated annualized yields are also provided for each company.